What is MeiraGTx Holdings PLC (MGTX) stock price today?

MeiraGTx Holdings PLC (MGTX) currently trades at $9.22 per share. The stock has a market capitalization of $840.42M and a P/E ratio of —x.

Is MGTX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, MeiraGTx Holdings PLC has a Smart Value Score of 37/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is MeiraGTx Holdings PLC's revenue and earnings?

MeiraGTx Holdings PLC has trailing twelve-month (TTM) revenue of $81.39M with profit margins of -140.30%. Earnings per share (EPS) is $-1.42.

Is MGTX stock overvalued or undervalued?

Based on our DCF model, MeiraGTx Holdings PLC's intrinsic value is $22.89, representing a margin of safety of 67.41%. The stock currently trades at a P/E of —x.

MGTX

MeiraGTx Holdings PLC

NASDAQ: MGTX · HEALTHCARE · BIOTECHNOLOGY

$9.22

+3.02% today

Updated 2026-04-30

Market cap

$840.42M

P/E ratio

—

P/S ratio

10.33x

EPS (TTM)

$-1.42

Dividend yield

—

52W range

$5 – $12

Volume

0.7M

Market cap

$840.42M

P/E ratio

—

P/S ratio

10.33x

EPS (TTM)

$-1.42

Dividend yield

—

52W range

$5 – $12

Volume

0.7M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

4.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$27.88

+202.39%

12-Month target

—

Intrinsic (DCF)

$22.89

Margin of safety

+67.41%

2 Strong Buy6 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $39.86M — positive

+ Revenue growth 252.30% QoQ

+ 67.41% below intrinsic value

Risks

- Thin margins at -140.30%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$15.92M	$14.02M	$33.28M	$81.39M	$81.39M
Net income	$-129.62M	$-84.03M	$-147.79M	$-114.20M	$15.09M
EPS	—	—	—	—	$-1.42
Free cash flow	$-118.06M	$-125.54M	$-109.45M	$-50.19M	$39.86M
Profit margin	-814.16%	-599.46%	-444.10%	-140.31%	-140.30%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-07	NAYLOR, STUART	Sale	27,661	$9.36
2026-03-24	FORBES, ALEXANDRIA	Sale	62,000	$7.41
2026-02-21	ZELDIN, ROBERT K	Sale	7,500	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
MGTX	$840.42M	37	8.0	4.0	6.7	5.0	+67.41%	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

MeiraGTx Holdings PLC trades at $9.22. Our Smart Value Score of 37/100 indicates the stock is weak. TTM revenue stands at $81.39M. with profit margins at -140.30%. Our DCF model estimates intrinsic value at $22.89.

Frequently asked questions

What is MeiraGTx Holdings PLC's stock price?

MeiraGTx Holdings PLC (MGTX) trades at $9.22.

Is MeiraGTx Holdings PLC overvalued?

Smart Value Score 37/100 (Grade D, Sell). DCF value $22.89.

What is the price target of MeiraGTx Holdings PLC (MGTX)?

The analyst target price is $27.88, representing +202.4% upside from the current price of $9.22.

What is the intrinsic value of MeiraGTx Holdings PLC (MGTX)?

Based on our DCF model, intrinsic value is $22.89, a +67.4% margin of safety versus $9.22.

What is MeiraGTx Holdings PLC's revenue?

TTM revenue is $81.39M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio10.33x

ROE-368.20%

Beta1.28

50D MA$8.38

200D MA$8.12

Shares out0.09B

Float0.05B

Short ratio—

Avg volume0.7M

Performance

1 week-2.58%

1 month+4.85%

3 months+17.31%

YTD+14.21%

1 year—

3 years—

5 years—

Compare

MGTX vs LLY →MGTX vs JNJ →MGTX vs ABBV →Stock screener →